Evofem Biosciences, Inc.
EVFM
$0.0099
$0.00044.21%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 125.00K | 346.00K | 127.00K | 202.00K | -- |
| Total Receivables | 4.93M | 1.15M | 9.83M | 5.39M | 4.62M |
| Inventory | 1.91M | 2.26M | 1.58M | 1.46M | 1.06M |
| Prepaid Expenses | 868.00K | 162.00K | 1.85M | 627.00K | 488.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.14M | 1.95M | 2.42M | 892.00K | 1.05M |
| Total Current Assets | 8.97M | 5.87M | 13.61M | 8.58M | 7.21M |
|
|
|||||
| Total Current Assets | 8.97M | 5.87M | 13.61M | 8.58M | 7.21M |
| Net Property, Plant & Equipment | 638.00K | 481.00K | 547.00K | 1.31M | 1.30M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 4.74M | 6.49M | 9.60M | 14.02M | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 36.00K | 36.00K | 36.00K | 36.00K | 36.00K |
| Total Assets | 14.38M | 12.88M | 23.79M | 23.94M | 8.55M |
|
|
|||||
| Total Accounts Payable | 12.29M | 11.22M | 16.17M | 16.86M | 16.03M |
| Total Accrued Expenses | 6.58M | 5.89M | 9.00M | 8.35M | 8.03M |
| Short-term Debt | 47.10M | 45.67M | 15.11M | 14.45M | 13.64M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 124.00K | 48.00K | 30.85M | 30.32M | 29.76M |
| Total Finance Division Other Current Liabilities | 7.81M | 8.02M | 9.31M | 6.31M | 5.72M |
| Total Other Current Liabilities | 7.81M | 8.02M | 9.31M | 6.31M | 5.72M |
| Total Current Liabilities | 73.89M | 70.85M | 80.45M | 76.29M | 73.18M |
|
|
|||||
| Total Current Liabilities | 73.89M | 70.85M | 80.45M | 76.29M | 73.18M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 47.10M | 45.67M | 15.11M | 14.45M | 13.64M |
| Capital Leases | 89.00K | 5.00K | 7.00K | 10.00K | 1.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.23M | 6.82M | 9.81M | 13.78M | -- |
| Total Liabilities | 79.21M | 77.68M | 90.26M | 90.07M | 73.18M |
|
|
|||||
| Common Stock & APIC | 831.44M | 829.11M | 829.04M | 825.44M | 823.72M |
| Retained Earnings | -898.50M | -896.71M | -897.66M | -894.62M | -892.25M |
| Treasury Stock & Other | -2.56M | -1.98M | -2.63M | -1.71M | -781.00K |
| Total Common Equity | -69.62M | -69.59M | -71.26M | -70.89M | -69.32M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 4.79M | 4.79M | 4.78M | 4.76M | 4.69M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 4.79M | 4.79M | 4.78M | 4.76M | 4.69M |
|
|
|||||
| Total Common Equity | -69.62M | -69.59M | -71.26M | -70.89M | -69.32M |
| Total Preferred Equity | 4.79M | 4.79M | 4.78M | 4.76M | 4.69M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -64.83M | -64.80M | -66.48M | -66.13M | -64.63M |
|
|
|||||